ClinicalTrials.gg
RecruitingNCT06858488Updated Jul 22, 2026

Bioimpedance for Ortho Trauma

An interventional study of Extremity Surgery in Trauma Injury, sponsored by Dartmouth-Hitchcock Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-22.

Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 11 studies in Accidental Injuries by Dartmouth-Hitchcock Medical Center — 3 open to participants now, 3 under way, none of them phase 3. Accidental Injuries · Dartmouth-Hitchcock Medical Center.

Started
2025
with 1 other
No phase
2 of 11
1 open now
Registered
11th of 11
by date

Among the 11 studies in Accidental Injuries by Dartmouth-Hitchcock Medical Center, this one is one of 2 that started in 2025, is one of 2 with no phase, and was the 11th registered.

Accidental Injuries

128 studies on the registry are indexed under Accidental Injuries; 39 are open to participants now.

Browse Accidental Injuries studies →

Open to participants now

3 of the 11 studies in Accidental Injuries by Dartmouth-Hitchcock Medical Center are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 24 Accidental Injuries studies recruiting now, 11 (46%) set no upper age limit and 6 (25%) stop at 75 or younger; 5 take children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Accidental Injuries by Dartmouth-Hitchcock Medical Center, or all of them as a file.
02

Study summary

Patients with high-energy extremity trauma will undergo imaging with an EIT device in the Emergency Department, Operating Room, Orthopaedic Clinic, and In-patient hospital rooms. The EIT device is an electrical impedance tomography system.

03

Conditions studied

  • Trauma Injury

Browse trials for

Keywords

  • Orthopedics
  • Extremity fracture
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • High energy closed extremity fracture
  • Provision of

Exclusion criteria

Exclusion Criteria:

  • Metatarsal fractures
  • Injury to both lower extremities precluding contralateral imaging
  • Presence of an implanted electronic device (e.g. pacemaker, vagal stimulator, deep brain stimulator) or electrodes or electrical wires.
  • Currently pregnant, potentially pregnant, or lactating women
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Extremity fracture

    High energy closed extremity fractures

    Procedure: Extremity Surgery

Interventions

  • ProcedureExtremity Surgery

    Patients 18 years of age or older with high energy closed extremity fractures. Provision of informed consent.

06

What researchers measure

Primary outcomes

  1. Feasibility and acceptability of the EIT device

    The primary objective of this work is to explore whether changes in impedance measurement associated with EIT are associated with soft tissue injury and readiness for surgical intervention. EIT is a technique which introduces a small amount of electrical current into biologic tissue through an array of electrodes and measures the change in signal to generate images related to the physiology of that tissue.

    Time frame: 20 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Jul 2027, 28 months after the start.

Of 34 non-industry interventional studies with no phase under Accidental Injuries, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 51. This study's planned 28 months is above that.

Counting every sponsor, half of 35 studies reached it within 23 months; a quarter within 7 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2025
First posted
Mar 5, 2025
StartActual
Mar 20, 2025
Primary completionEst.
Jul 2027
CompletionEst.
Jul 2028
Last update
Jul 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06858488
Collaborators
Dartmouth College
Responsible party
Ida Leah Gitajn (Section Chief, Orthopaedics, Dartmouth-Hitchcock Medical Center) — Principal investigator
First posted
Mar 5, 2025
Start date
Mar 20, 2025
Primary completion
Jul 2027 (estimated)
Completion
Jul 2028 (estimated)
Last update
Jul 22, 2026

Study contacts

Holly B Symonds
Contact
Holly.B.Symonds@hitchcock.org
603-653-9440
Ida L Gitajn, MD
principal investigator · Dartmouth-Hitchcock Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion